ANGONASDAQ
AngioDynamics, Inc.
$0.00
0.000.00%
15-min delay
E
Open—
Prev Close—
Market Cap$454.61M
EPS-$0.15
Earnings2027-01-07
DAY RANGE
$0.00$0.00

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

SectorHealth Technology
Employees748
ISINUS03475V1017
Address14 Plaza Drive, Latham, NY, 12110
Key Statistics
Full Stats
Market Cap$454.61M
Enterprise Value$431.37M
P/E Ratio (TTM)—
P/S Ratio1.39
P/B Ratio2.80
Forward P/E—
EPS (TTM)-$0.79
EPS (FY)-$0.15
Revenue (TTM)$325.38M
Profit Margin-10.12%
Operating Margin-6.01%
ROE-20.77%
Debt/Equity0.07
Avg Vol (30d)674K
Beta (1Y)-0.16
Beta (3Y)0.25
Beta (5Y)0.29
Shares Out42.05M
Float37.21M
Dividend—
Next Earnings2027-01-07
Short Interest—
52-Week Range
$0.00
$9.39$16.29

Upgrades & Downgrades

Members

Every rating change, who made it, and what it moved from.

Sign in to viewCreate a free account

Free account. No card required.

Grades Consensus

Members

Analyst price targets — high, low, median and where it sits now.

Sign in to viewCreate a free account

Free account. No card required.

Price Target Consensus

Members

Analyst price targets — high, low, median and the upside from here.

Sign in to viewCreate a free account

Free account. No card required.

Ratings Snapshot

Members

DCF, Piotroski, Altman Z and returns scores, in one grade.

Sign in to viewCreate a free account

Free account. No card required.

Forward Estimates

Members

Quarterly revenue and EPS estimates, with the history of beats.

Sign in to viewCreate a free account

Free account. No card required.

Seasonality

Members

How this ticker has traded month by month over the last decade.

Sign in to viewCreate a free account

Free account. No card required.